Jyothy Labs Limited promoters may reach 63.95% after buyback

Jyothy Labs Limited’s promoters and persons in control may hold 63.95% after the proposed buyback, up from 62.88%, if eligible non-promoter shareholders tender 61,25,000 shares in full. The increase would result from cancelling shares while the promoter group, which declined to participate on November 4, 2026, retains its 23,09,34,685 shares.

Why could Jyothy Labs’ promoter holding rise without buying shares?

Jyothy Labs’ promoter holding could rise because the group’s 23,09,34,685 shares would remain outstanding while shares accepted from other eligible holders would be extinguished. The promoter, promoter group and persons in control held 62.88% on November 4, 2026, the board-meeting date, and November 5, 2026, the public-announcement date.

Under Jyothy Labs’ full-acceptance illustration, that unchanged shareholding would represent 63.95% of post-buyback equity capital, an increase of 107 basis points or 1.07 percentage points. Public shareholding would correspondingly decrease to 36.05% from 37.12%. This is a conditional capital-reduction outcome, rather than a promoter purchase or an allotment of new shares.

Jyothy Labs said its promoters and promoter group, who are the persons in control, informed it by letter dated November 4, 2026 that they did not intend to participate in the tender offer. The final percentage will depend on actual acceptances, since the 63.95% illustration assumes 100% acceptance from eligible shareholders up to their entitlement.

What are Jyothy Labs’ revised buyback terms?

Jyothy Labs proposes to buy back up to 61,25,000 equity shares at Rs 240 each for an aggregate consideration not exceeding Rs 147 crore and Rs 150, excluding transaction costs. The offer uses the tender-offer route and applies to shareholders on the November 11, 2026 record date, subject to applicable legal restrictions.

The board approved an original proposal on November 4, 2026 for up to 68,37,210 shares at Rs 215 each. On November 9, 2026, the buyback committee raised the price by Rs 25 per share to Rs 240 and lowered the maximum share count by 7,12,210 shares, while retaining the same buyback size.

The revised share count represents 1.67% of paid-up equity share capital as of March 31, 2026, compared with 1.86% under the original proposal. The offer size represents 9.70% of aggregate paid-up equity share capital and free reserves, below the 10% limit cited by Jyothy Labs under the Companies Act and Securities and Exchange Board of India, or SEBI, buyback regulations.

BSE Limited will provide the designated acquisition window for sell orders from eligible shareholders. Jyothy Labs said all shares acquired in the buyback will be extinguished, and its standalone debt-to-equity ratio would remain below the 2:1 regulatory limit even if the offer receives full acceptance.

Who holds control of Jyothy Labs before the buyback?

Jyothy Labs is already controlled by its promoter and promoter-group shareholders, whose combined 23,09,34,685 shares equal 62.88% of equity capital. M. P. Ramachandran Family Trust - II is the largest disclosed group holder with 14,36,39,870 shares, representing 39.11%.

Other disclosed holdings include Sahyadri Agencies Limited at 3.95%, M P Divakaran at 3.94%, M P Sidharthan at 2.84%, M R Jyothy at 2.82% and M.R.Deepthi at 2.82%. M. P. Ramachandran Family Trust - I held 64,11,011 shares, or 1.75%, while M. P. Ramachandran held 1,001 shares.

The two family trusts entered the promoter-group category on November 15, 2025 after receiving 64,11,011 shares and 14,36,39,870 shares respectively through gifts. Jyothy Labs said the transfers, made by M. P. Ramachandran and M. G. Shanthakumari, were intended to streamline succession and family welfare under a SEBI exemption order dated October 26, 2025.

The filing said promoter-group members, persons in control, relevant trust or company directors, directors and key managerial personnel made no share purchases or sales in the six months before the November 4 board meeting and 12 months before the public announcement, apart from listed gifts and employee stock-option allotments. Promoter and promoter-group securities are frozen at the International Securities Identification Number level from November 4 until the offer closes, subject to permitted tendering.

How would Jyothy Labs’ financial measures change after full acceptance?

Jyothy Labs projects basic and diluted earnings per share of Rs 9.23 after full acceptance, compared with Rs 9.07 before the buyback. The calculation uses a weighted average share count of 36,10,89,511 after the transaction, down from 36,72,14,511 for the year ended March 31, 2026.

Net worth would decline to Rs 1,441.61 crore from Rs 1,588.61 crore under the full-acceptance assumption, excluding the effect of transaction costs in the statement of profit and loss. Return on net worth would increase to 23.1% from 21.0%, while book value per share would decrease to Rs 39.92 from Rs 43.26.

Jyothy Labs said the buyback is not likely to affect profitability or earnings except through lower investment income from funds otherwise available for investment. It reported cash and investments of Rs 996.56 crore at March 31, 2026 and said it had considered working capital, capital expenditure, potential acquisitions and contingencies before proposing the offer.

Funding will come from free reserves, securities premium and other legally permitted sources rather than bank or financial-institution borrowings. Jyothy Labs deposited Rs 29.70 crore and Rs 15 in an ICICI Bank Limited escrow account on November 5, 2026, and a November 11 certificate stated that the company had adequate financial arrangements for the buyback.

Conclusion

Jyothy Labs’ proposed buyback gives eligible shareholders a Rs 240-per-share tender option and could further concentrate proportional promoter ownership without a promoter acquisition. Full acceptance of 61,25,000 shares would reduce the share base and move promoter and persons-in-control ownership from 62.88% to 63.95%, while leaving control with the same group.

The next disclosed variable is the tender response following the November 11, 2026 record date, which will determine actual cancellations and the final ownership split. Jyothy Labs also said it cannot issue equity shares until the buyback period ends, except for subsisting obligations, and generally cannot raise further capital for one year after that period, subject to regulatory exceptions.